These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 10640351)

  • 1. A high-throughput assay to identify compounds that can induce dimerization of the erythropoietin receptor.
    Biazzo DE; Motamedi H; Mark DF; Qureshi SA
    Anal Biochem; 2000 Feb; 278(1):39-45. PubMed ID: 10640351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased potency of an erythropoietin peptide mimetic through covalent dimerization.
    Wrighton NC; Balasubramanian P; Barbone FP; Kashyap AK; Farrell FX; Jolliffe LK; Barrett RW; Dower WJ
    Nat Biotechnol; 1997 Nov; 15(12):1261-5. PubMed ID: 9359108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of new multimeric erythropoietin receptor agonists.
    Vadas O; Hartley O; Rose K
    Biopolymers; 2008; 90(4):496-502. PubMed ID: 18273892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective properties of a novel, non-haematopoietic agonist of the erythropoietin receptor.
    Pankratova S; Kiryushko D; Sonn K; Soroka V; Køhler LB; Rathje M; Gu B; Gotfryd K; Clausen O; Zharkovsky A; Bock E; Berezin V
    Brain; 2010 Aug; 133(Pt 8):2281-94. PubMed ID: 20435631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficiency of signalling through cytokine receptors depends critically on receptor orientation.
    Syed RS; Reid SW; Li C; Cheetham JC; Aoki KH; Liu B; Zhan H; Osslund TD; Chirino AJ; Zhang J; Finer-Moore J; Elliott S; Sitney K; Katz BA; Matthews DJ; Wendoloski JJ; Egrie J; Stroud RM
    Nature; 1998 Oct; 395(6701):511-6. PubMed ID: 9774108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivalency - a way to enhance binding avidities and bioactivity - preliminary applications to EPO.
    Vadas O; Rose K
    J Pept Sci; 2007 Sep; 13(9):581-7. PubMed ID: 17631671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cloning cDNA of extracellular domain of human erythropoietin receptor and its expression in Escherichia coli].
    Zhang YH; Lu YF; Liu YP; Deng JX
    Sheng Wu Gong Cheng Xue Bao; 2000 May; 16(3):328-32. PubMed ID: 11059274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dimer formation of receptor activator of nuclear factor kappaB induces incomplete osteoclast formation.
    Iwamoto K; Miyamoto T; Sawatani Y; Hosogane N; Hamaguchi I; Takami M; Nomiyama K; Takagi K; Suda T
    Biochem Biophys Res Commun; 2004 Dec; 325(1):229-34. PubMed ID: 15522223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-level expression of human stem cell factor fused with erythropoietin mimetic peptide in Escherichia coli.
    Su L; Chen SS; Yang KG; Liu CZ; Zhang YL; Liang ZQ
    Protein Expr Purif; 2006 Jun; 47(2):477-82. PubMed ID: 16356735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin-dependent autocrine secretion of tumor necrosis factor-alpha in hematopoietic cells modulates proliferation via MAP kinase--ERK-1/2 and does not require tyrosine docking sites in the EPO receptor.
    Chen J; Jacobs-Helber SM; Barber DL; Sawyer ST
    Exp Cell Res; 2004 Aug; 298(1):155-66. PubMed ID: 15242770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino acid determinants of beta-hairpin conformation in erythropoeitin receptor agonist peptides derived from a phage display library.
    Skelton NJ; Russell S; de Sauvage F; Cochran AG
    J Mol Biol; 2002 Mar; 316(5):1111-25. PubMed ID: 11884148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning and expression pattern of the Xenopus erythropoietin receptor.
    Yergeau DA; Schmerer M; Kuliyev E; Evans T; Mead PE
    Gene Expr Patterns; 2006 Apr; 6(4):420-5. PubMed ID: 16378761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dimerization of the erythropoietin receptor transmembrane domain in micelles.
    Ebie AZ; Fleming KG
    J Mol Biol; 2007 Feb; 366(2):517-24. PubMed ID: 17173930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A "classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells.
    Um M; Gross AW; Lodish HF
    Cell Signal; 2007 Mar; 19(3):634-45. PubMed ID: 17045782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 2.8 A.
    Livnah O; Stura EA; Johnson DL; Middleton SA; Mulcahy LS; Wrighton NC; Dower WJ; Jolliffe LK; Wilson IA
    Science; 1996 Jul; 273(5274):464-71. PubMed ID: 8662530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide agonists of the thrombopoietin receptor.
    Dower WJ; Cwirla SE; Balasubramanian P; Schatz PJ; Baccanari DP; Barrett RW
    Stem Cells; 1998; 16 Suppl 2():21-9. PubMed ID: 11012174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginine mutations within a transmembrane domain of Tar, an Escherichia coli aspartate receptor, can drive homodimer dissociation and heterodimer association in vivo.
    Sal-Man N; Shai Y
    Biochem J; 2005 Jan; 385(Pt 1):29-36. PubMed ID: 15330757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino-terminal dimerization of an erythropoietin mimetic peptide results in increased erythropoietic activity.
    Johnson DL; Farrell FX; Barbone FP; McMahon FJ; Tullai J; Kroon D; Freedy J; Zivin RA; Mulcahy LS; Jolliffe LK
    Chem Biol; 1997 Dec; 4(12):939-50. PubMed ID: 9427659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The full-length, cytoplasmic C-terminus of the beta 2-adrenergic receptor expressed in E. coli acts as a substrate for phosphorylation by protein kinase A, insulin receptor tyrosine kinase, GRK2, but not protein kinase C and suppresses desensitization when expressed in vivo.
    Doronin S; Lin F; Wang HY; Malbon CC
    Protein Expr Purif; 2000 Dec; 20(3):451-61. PubMed ID: 11087685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of erythropoietin on Leydig cell is associated with the activation of Stat5 pathway.
    Yamazaki T; Kanzaki M; Kamidono S; Fujisawa M
    Mol Cell Endocrinol; 2004 Jan; 213(2):193-8. PubMed ID: 15062567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.